| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
26,510,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rain Therapeutics is a late-stage precision oncology company developing therapies that target oncogenic drivers for which Co. is able to genetically select patients most likely to benefit. Co.'s primary product candidate, milademetan, is a small molecule, oral inhibitor of mouse double minute 2, which may be oncogenic in various cancers. In addition to milademetan, Co. is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,372,418 |
4,244,869 |
| Total Buy Value |
$0 |
$0 |
$1,437,794 |
$18,372,213 |
| Total People Bought |
0 |
0 |
1 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
12 |
| Total Shares Sold |
0 |
173,973 |
1,168,973 |
1,168,973 |
| Total Sell Value |
$0 |
$209,413 |
$1,453,163 |
$1,453,163 |
| Total People Sold |
0 |
1 |
2 |
2 |
| Total Sell Transactions |
0 |
3 |
4 |
4 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tang Capital Partners Lp |
10% Owner |
– – • |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,850,513) |
0 |
|
- |
|
| Davis Aaron I. |
Director |
– • – |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(79,726) |
0 |
|
- |
|
| Radovich Peter |
Director |
– • – |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,796) |
0 |
|
- |
|
| Berger Franklin M |
Director |
– • – |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,005,207) |
0 |
|
- |
|
| Vellanki Avanish |
Chairman and CEO |
• • – |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,550,910) |
0 |
|
- |
|
| Doebele Robert |
See Remarks |
• – – |
2024-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(476,827) |
0 |
|
- |
|
| Lampert Mark N |
See Remarks; Former 10% Owner |
– • – |
2024-01-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,288,617) |
0 |
|
- |
|
| Lampert Mark N |
See Remarks; Former 10% Owner |
– • – |
2024-01-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,288,186) |
0 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-12-18 |
4 |
S |
$1.21 |
$48,560 |
I/I |
(40,132) |
3,850,513 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-12-15 |
4 |
S |
$1.20 |
$131,322 |
I/I |
(109,435) |
3,890,645 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-12-14 |
4 |
S |
$1.21 |
$29,531 |
I/I |
(24,406) |
4,000,080 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-10-13 |
4 |
B |
$0.99 |
$130,315 |
I/I |
131,631 |
4,024,486 |
1.5 |
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-10-12 |
4 |
B |
$0.98 |
$76,148 |
I/I |
77,702 |
3,892,855 |
1.5 |
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-10-11 |
4 |
B |
$0.97 |
$72,568 |
I/I |
74,812 |
3,815,153 |
1.5 |
- |
|
| Bruce Josephine |
Principal Fin. & Acc. OfficerO |
• – – |
2023-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,588 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-06-01 |
4 |
B |
$1.09 |
$370,534 |
I/I |
333,325 |
3,740,341 |
1.5 |
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-05-31 |
4 |
B |
$1.08 |
$179,574 |
I/I |
166,180 |
3,407,016 |
1.5 |
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-05-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,652,068 |
|
- |
|
| Tang Capital Partners Lp |
10% Owner |
– – • |
2023-05-30 |
4 |
B |
$1.00 |
$608,655 |
I/I |
588,768 |
3,240,836 |
1.5 |
- |
|
| Davis Aaron I. |
See remarks. |
• • – |
2023-05-22 |
4 |
S |
$1.25 |
$1,243,750 |
D/D |
(995,000) |
1,152,212 |
|
- |
|
| Berger Franklin M |
Director |
– • – |
2022-11-22 |
4 |
B |
$8.27 |
$636,790 |
D/D |
77,000 |
1,005,207 |
2.39 |
- |
|
| Berger Franklin M |
Director |
– • – |
2022-11-21 |
4 |
B |
$7.80 |
$351,000 |
D/D |
45,000 |
928,207 |
2.39 |
- |
|
| Berger Franklin M |
Director |
– • – |
2022-11-08 |
4 |
B |
$5.83 |
$249,996 |
D/D |
42,881 |
883,207 |
2.39 |
- |
|
| Lampert Mark N |
See Explanation of Responses |
– • • |
2022-11-08 |
4 |
B |
$5.83 |
$9,971,387 |
D/D |
1,710,358 |
341,547 |
3.92 |
- |
|
| Davis Aaron I. |
Director |
– • – |
2022-11-04 |
4 |
B |
$5.83 |
$5,667,996 |
I/I |
972,212 |
2,147,212 |
2.1 |
- |
|
67 Records found
|
|
Page 1 of 3 |
|
|
